Κυριακή, 17 Δεκεμβρίου 2017

Τετάρτη, 26 Οκτωβρίου 2016 NEW VENUE
Divani Caravel Hotel,
Αίθουσα Macedonia

Παρουσιάσεις ομιλητών του Workshop on Securing patients’ access

"Securing patients’ access to vital therapeutic solutions for rare, life-threatening, chronic and genetic diseases"

Konstantinos Panagoulias, General Manager, Vian, Vice-President, Vianex

Κατεβάστε την παρουσίαση locked (Zip 1445 KB)

"Exempting rare diseases from hospital clawback mechanism"

Christos Dakas, Vice President, Pharma Innovation Forum, CEO Shire Greece

Κατεβάστε την παρουσίαση locked (Zip 1937 KB)

"Access to orphan drugs for patients with rare diseases"

Antonis Avgerinos, Secretary General of the Scientific Society for Rare Diseases & Orphan Drugs (EESPOF), President of the Hellenic Red Cross

Κατεβάστε την παρουσίαση locked (Zip 734 KB)

"Rare Disease Patients: access to orphan drugs"

Aikaterini Theoharis, President, Panhellenic Association of Patients & Friends suffering from Lysosomal Diseases "The Solidarity"

Κατεβάστε την παρουσίαση locked (Zip 852 KB)

"Comprehensive review of the current landscape in Greece: availability, reimbursement, pricing issues"

Isidoros Kougioumtzoglou, Market Access Manager, Vianex, Member of the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE)

Κατεβάστε την παρουσίαση locked (Zip 1759 KB)

"Treating rare diseases in Greece: real life scientific data"

Ilias Gountas, Scientific Associate, Doctoral Candidate, Laboratory of Hygiene, Epidemiology and Medical Statistics, Medical School - University of Athens

Κατεβάστε την παρουσίαση locked (Zip 1623 KB)

"Looking directly the hospital clawback mechanism and how this affects patient access"

Didier Cochet, General Manager, Sanofi-Genzyme

Κατεβάστε την παρουσίαση locked (Zip 958 KB)

"Rare diseases in secondary care"

Anastasia Balasopoulou, General Manager Hippokrateio Hospital, ΜSc in Decision Making, Operational Research Department, London School of Economics

Κατεβάστε την παρουσίαση locked (Zip 539 KB)

"Orphan drugs, BDPs and plasma therapies: inelastic and predictable spending for absolutely vital treatments"

Marianna Konstantinidi, General Manager, CSL Behring

Κατεβάστε την παρουσίαση locked (Zip 913 KB)

"Creating a sustainable environment for rare diseases patients"

Olympios Papadimitriou, General Manager, Novo Nordisk Hellas LTD

Κατεβάστε την παρουσίαση locked (Zip 1399 KB)
  • ΜΕΓΑΛΟΣ ΧΟΡΗΓΟΣ

Δείτε τους όρους χρήσης. Επικοινωνήστε μαζί μας.

© 2017 Boussias Communications, all rights reserved. Κλεισθένους 338, 153 44 Γέρακας, info@boussias.com, T:210 6617777, F:210 6617778

Designed by Boussias
New Media Team